Danaher’s (DHR) Outperform Rating Reiterated at Credit Suisse Group

Share on StockTwits

Credit Suisse Group reaffirmed their outperform rating on shares of Danaher (NYSE:DHR) in a research note issued to investors on Friday, March 9th.

A number of other equities research analysts have also recently weighed in on the company. Deutsche Bank dropped their price objective on Danaher from $114.00 to $107.00 and set a buy rating for the company in a research note on Thursday, March 1st. Barclays began coverage on Danaher in a research note on Thursday, February 15th. They issued an overweight rating and a $110.00 price objective for the company. Argus lifted their price objective on Danaher from $100.00 to $115.00 and gave the company a buy rating in a research note on Thursday, February 1st. Royal Bank of Canada reaffirmed a hold rating and issued a $98.00 price objective on shares of Danaher in a research note on Wednesday, January 31st. Finally, Stifel Nicolaus lifted their price objective on Danaher from $110.00 to $115.00 and gave the company a buy rating in a research note on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of Buy and an average target price of $102.23.

DHR stock traded up $2.13 during midday trading on Friday, hitting $98.23. 2,164,829 shares of the company’s stock were exchanged, compared to its average volume of 2,576,388. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. The stock has a market cap of $68,299.03, a price-to-earnings ratio of 24.37, a price-to-earnings-growth ratio of 2.06 and a beta of 1.03. Danaher has a 1-year low of $78.97 and a 1-year high of $104.82.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.03. The company had revenue of $5.09 billion during the quarter, compared to analysts’ expectations of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The firm’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.05 earnings per share. sell-side analysts anticipate that Danaher will post 4.38 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Thursday, March 29th will be issued a $0.16 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Wednesday, March 28th. Danaher’s payout ratio is presently 15.88%.

In other news, Director Walter G. Lohr sold 10,578 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $97.90, for a total value of $1,035,586.20. Following the completion of the sale, the director now directly owns 19,821 shares of the company’s stock, valued at approximately $1,940,475.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Rainer Blair sold 3,981 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $100.05, for a total value of $398,299.05. Following the completion of the transaction, the insider now owns 49,751 shares in the company, valued at approximately $4,977,587.55. The disclosure for this sale can be found here. Insiders sold a total of 313,260 shares of company stock valued at $31,657,786 over the last three months. Company insiders own 12.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of DHR. Point72 Asset Management L.P. increased its position in Danaher by 276.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,626,865 shares of the conglomerate’s stock valued at $225,332,000 after acquiring an additional 1,929,751 shares during the period. BlackRock Inc. increased its position in Danaher by 4.6% during the 4th quarter. BlackRock Inc. now owns 40,984,366 shares of the conglomerate’s stock worth $3,804,169,000 after purchasing an additional 1,789,474 shares during the period. Findlay Park Partners LLP increased its position in Danaher by 52.9% during the 3rd quarter. Findlay Park Partners LLP now owns 4,117,348 shares of the conglomerate’s stock worth $353,186,000 after purchasing an additional 1,425,000 shares during the period. JPMorgan Chase & Co. increased its position in Danaher by 86.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,011,947 shares of the conglomerate’s stock worth $256,136,000 after purchasing an additional 1,393,165 shares during the period. Finally, Evercore Trust Company N.A. acquired a new position in Danaher during the 3rd quarter worth approximately $113,606,000. Hedge funds and other institutional investors own 77.66% of the company’s stock.

WARNING: “Danaher’s (DHR) Outperform Rating Reiterated at Credit Suisse Group” was reported by BBNS and is the sole property of of BBNS. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://baseballnewssource.com/2018/04/03/danaher-dhr-earns-neutral-rating-from-credit-suisse-group/2016657.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.